Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 85 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/20/25
End: 04/30/31
Due: 04/30/32
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 10/03/22
End: 08/31/29
Due: 08/31/30
Phase: N/A
Priority: Normal
Start: 05/17/21
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 11/25/24
End: 03/01/37
Due: 03/01/38
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 03/31/22
Due: 03/31/23
Phase: N/A
Priority: Normal
Start: 10/17/23
End: 01/31/32
Due: 01/31/33
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 02/28/23
Due: 02/28/24
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 01/31/11
Due: 01/31/12
Phase: N/A
Priority: Normal
Start: 12/19/17
End: 12/31/27
Due: 12/31/28
Evaluation of the GORE® VIABAHN® Endoprosthesis for the Treatment of Popliteal Artery Aneurysm (PAA)
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 01/06/17
Due: 01/06/18
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 06/30/21
Due: 06/30/22
Phase: N/A
Priority: Normal
Start: 03/02/23
End: 03/31/31
Due: 03/31/32
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 10/31/12
Due: 10/31/13
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/01/16
End: 02/14/21
Due: 02/14/22
Phase: N/A
Priority: Normal
Start: 02/28/03
End: 08/31/07
Due: 08/31/08
Phase: N/A
Priority: Normal
Start: 02/01/24
End: 08/01/28
Due: 08/01/29
Phase: N/A
Priority: Normal
Start: 07/02/20
End: 10/06/23
Due: 10/06/24
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 07/31/14
End: 10/31/18
Due: 10/31/19